All Stories

  1. 69 Peripheral neuropathy profile in Pediatric-onset Metachromatic Leucodystrophy vs Krabbe Disease
  2. Beyond ICHD-3 criteria: Diagnostic challenges in headache in pediatric age
  3. Migraine in pediatric population: the role of biochemical markers
  4. Sex-specific orchestration of morphometric similarity networks in children and adolescents with migraine
  5. Unseen struggles: a narrative review of psychosocial and family outcomes following pediatric stroke
  6. Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Fremanezumab in Children and Adolescents with Migraine
  7. Bladder and Bowel Management in Adolescents and Young Adults with Multiple Sclerosis Since Childhood: Is Bowel Management Overlooked? A Case Series
  8. Responsible use of large language models in manuscript authorship, peer review, and editorial processes: a Delphi consensus among editors-in-chief of anaesthesia and pain medicine journals (RULE-AP)
  9. Quality of life and disease burden in tuberous sclerosis and comparison with the population with idiopathic autism spectrum disorder: an investigation conducted through questionnaires and clinical data collection in the pediatric population
  10. Ictal vomiting as the first manifestation of Tuberous Sclerosis Complex: report of two pediatric cases
  11. Complete Epstein-Barr virus seropositivity in a cohort of pediatric onset multiple sclerosis: a comparison to other autoimmune diseases
  12. From brain injury to classroom: cognitive and academic outcomes after pediatric stroke. A narrative review
  13. Hallmarks of primary headache: part 3 – cluster headache
  14. Onabotulinumtoxin-A for Chronic Migraine in Children and Adolescents: A Narrative Review of Current Evidence and Clinical Perspectives
  15. Somatosensory coding of visual self-identity
  16. Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee
  17. Restless legs syndrome and growing pains in childhood: understanding the link
  18. Development and Adaptive Function in Individuals With SCN2A -Related Disorders
  19. A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis
  20. Pediatric-Onset Multiple Sclerosis and Primary Headache: Is There a Link?
  21. Clinical Variability of Pediatric MERS: Insights from a Retrospective Observational Study
  22. Sleep Disorders in a Sample of Patients with Pediatric-Onset Multiple Sclerosis: Focus on Restless Legs Syndrome
  23. RHOBTB2-related paroxysmal hemiparesis: From alternating hemiplegia to hemiplegic migraine
  24. Sleep-related painful erection: the first case in a child
  25. Diagnosing migraine in children and adolescence using ID migraine: results of an Italian multicenter validation
  26. Autism spectrum disorder and 3p24.3p23 triplication: a case report
  27. Childhood and adolescent headache: A problem not to be ignored in the era of new therapies
  28. Therapeutic approach to fibromyalgia: a consensus statement on pharmacological and non-pharmacological treatment from the neuropathic pain special interest group of the Italian neurological society
  29. Ocrelizumab dose selection for treatment of pediatric relapsing–remitting multiple sclerosis: results of the OPERETTA I study
  30. Coping strategies to stressful events in adolescents with migraine
  31. Hallmarks of primary headache: part 1 – migraine
  32. Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions
  33. Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation
  34. Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
  35. Isolated Intracranial Hypertensions as Onset of Myelin Oligodendrocyte Glycoprotein Antibody Disease
  36. Headache in Sturge–Weber syndrome: A systematic review
  37. Lower Urinary Tract Dysfunction in Pediatric Patients with Multiple Sclerosis: Diagnostic and Management Concerns
  38. ID-Migraine test for pediatric population: preliminary results from the Italian validation
  39. Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine
  40. The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review
  41. Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series
  42. Cluster Headache: Diagnosis, Management, and Treatment in Pediatric Headache
  43. Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome
  44. Parental Experiences in Pediatric Multiple Sclerosis: Insights from Quantitative Research
  45. Childhood primary stabbing headache: A double center study
  46. Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents
  47. Neuropsychological performances, quality of life, and psychological issues in pediatric onset multiple sclerosis: a narrative review
  48. Gut Microbiota Ecological and Functional Modulation in Post-Stroke Recovery Patients: An Italian Study
  49. Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
  50. Pain-Related Evoked Potentials
  51. Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents – A questionnaire-based study
  52. Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study
  53. Clinical criteria and diagnostic assessment of fibromyalgia: position statement of the Italian Society of Neurology-Neuropathic Pain Study Group
  54. Migraine, Allergy, and Histamine: Is There a Link?
  55. A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome
  56. Visual Disturbances Spectrum in Pediatric Migraine
  57. Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age
  58. Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients
  59. Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic
  60. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience
  61. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
  62. Migraine in childhood: Gender differences
  63. Headache Features in Children and Adolescents with COVID-19
  64. Neuropathic Pain
  65. Assessment of C Fibers Evoked Potentials in Healthy Subjects by Nd : YAP Laser
  66. Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
  67. Secondary Narcolepsy as Worsening Sign in a Pediatric Case of Optic Pathway Glioma
  68. Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit
  69. Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History
  70. From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?
  71. Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review
  72. Epilepsy Course and Developmental Trajectories in STXBP1-DEE
  73. Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex
  74. Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination
  75. Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage
  76. Developmental Regression, Hypertension, and Pink Extremities in Childhood Mercury Poisoning
  77. The Enigma of New Daily Persistent Headache: What Solutions for Pediatric Age?
  78. Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report
  79. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study
  80. Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
  81. How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents
  82. Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns
  83. High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample
  84. The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons
  85. Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
  86. Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review
  87. Modulation of the N13 component of the somatosensory evoked potentials in an experimental model of central sensitization in humans
  88. Case Report: Migralepsy: The Two-Faced Janus of Neurology
  89. Can Clinical Neurophysiology Find the Pathophysiological Signature of Migraine in Children?
  90. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes
  91. Contribution of different somatosensory afferent input to subcortical somatosensory evoked potentials in humans
  92. Contribution of different somatosensory afferent input to subcortical somatosensory evoked potentials in humans
  93. Fingolimod in pediatric multiple sclerosis: Six case reports
  94. Symposium Title: The Contribution of Neurophysiology to Migraine: From Basic Mechanisms to the Effects of Novel Treatments
  95. Age‐related sensory neuropathy in patients with spinal muscular atrophy type 1
  96. Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study
  97. Truths and Myths in Pediatric Migraine and Nutrition
  98. Headache in Children and Adolescents: A Focus on Uncommon Headache Disorders
  99. Circulating long non-coding RNA signature in knee osteoarthritis patients with postoperative pain one-year after total knee replacement
  100. Early alterations of cortical thickness and gyrification in migraine without aura: a retrospective MRI study in pediatric patients
  101. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies
  102. Corrigendum: Major Stress-Related Symptoms During the Lockdown: A Study by the Italian Society of Psychophysiology and Cognitive Neuroscience
  103. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes
  104. Major Stress-Related Symptoms During the Lockdown: A Study by the Italian Society of Psychophysiology and Cognitive Neuroscience
  105. Features and Management of New Daily Persistent Headache in Developmental-Age Patients
  106. Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome
  107. Management of pediatric post-infectious neurological syndromes
  108. Fingolimod in pediatric multiple sclerosis: three case reports
  109. Expanding the Clinical and Mutational Spectrum of the PLP1-Related Hypomyelination of Early Myelinated Structures (HEMS)
  110. Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge
  111. Homotopic reduction in laser‐evoked potential amplitude and laser‐pain rating by abdominal acupuncture
  112. Conditioned pain modulation affects the N2/P2 complex but not the N1 wave: A pilot study with laser‐evoked potentials
  113. Cyclic Vomiting Syndrome in Children
  114. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children
  115. Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine
  116. Neurophysiology in Children and Elderlies with Migraine
  117. Pain-Related Evoked Potentials
  118. Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study
  119. Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
  120. Pearl and pitfalls in brain functional analysis by event-related potentials: a narrative review by the Italian Psychophysiology and Cognitive Neuroscience Society on methodological limits and clinical reliability—part II
  121. Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity?
  122. Methodological limits and clinical reliability of ERPs.
  123. Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study
  124. ZNRD1‐AS and RP11‐819C21.1 long non‐coding RNA changes following painful laser stimulation correlate with laser‐evoked potential amplitude and habituation in healthy subjects: A pilot study
  125. Preoperative serum circulating microRNAs as potential biomarkers for chronic postoperative pain after total knee replacement
  126. Editorial: Clinical and Pathophysiological Peculiarities of Headache in Children and Adolescents
  127. Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome
  128. First Attack and Clinical Presentation of Hemiplegic Migraine in Pediatric Age: A Multicenter Retrospective Study and Literature Review
  129. T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica
  130. Pain in cervical dystonia: Evidence of abnormal inhibitory control
  131. Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
  132. Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
  133. Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study
  134. Cooling the skin for assessing small-fibre function
  135. A Delphi consensus statement of the Neuropathic Pain Special Interest Group of the Italian Neurological Society on pharmacoresistant neuropathic pain
  136. Cerebellar Transcranial Direct Current Stimulation (ctDCS) Ameliorates Phantom Limb Pain and Non-painful Phantom Limb Sensations
  137. Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria
  138. Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents
  139. Longitudinal gait assessment in a stiff person syndrome
  140. Low-Frequency rTMS of the Primary Motor Area Does Not Modify the Response of the Cerebral Cortex to Phasic Nociceptive Stimuli
  141. The Italian multiple sclerosis register
  142. Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria
  143. Laser evoked potential amplitude and laser-pain rating reduction during high-frequency non-noxious somatosensory stimulation
  144. Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations
  145. Maternal Alexithymia and Attachment Style: Which Relationship with Their Children’s Headache Features and Psychological Profile?
  146. Autoimmune Encephalitis in Children
  147. Neurophysiological Comparison Among Tonic, High Frequency, and Burst Spinal Cord Stimulation: Novel Insights Into Spinal and Brain Mechanisms of Action
  148. Two Brothers with Atypical UNC13D-Related Hemophagocytic Lymphohistiocytosis Characterized by Massive Lung and Brain Involvement
  149. Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria
  150. Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State
  151. Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta
  152. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents
  153. Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study
  154. Skin denervation does not alter cortical potentials to surface concentric electrode stimulation: A comparison with laser evoked potentials and contact heat evoked potentials
  155. IHC Posters - Thursday and Friday
  156. TBC1D24 gene mutations are associated with high risk of sudden unexpected death
  157. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study
  158. Diagnostic accuracy of laser-evoked potentials in diabetic neuropathy
  159. Acupuncture for Pain in Chronic Pancreatitis
  160. Venlafaxine and oxycodone have different effects on spinal and supraspinal activity in man: a somatosensory evoked potential study
  161. Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study
  162. Comorbidity with Fibromyalgia
  163. Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia
  164. Expectation to feel more pain disrupts the habituation of laser-pain rating and laser-evoked potential amplitudes
  165. Childhood-onset ATP1A3-related conditions: Report of two new cases of phenotypic spectrum
  166. Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives
  167. Diagnosis of primary headache in children younger than 6 years: A clinical challenge
  168. Alexithymia and psychopathological symptoms in adolescent outpatients and mothers suffering from migraines: a case control study
  169. Warmth and nociceptive evoked potentials in cold-induced sweating syndrome type 1
  170. Focal Mechanical Vibration Does not Change Laser-Pain Perception and Laser-Evoked Potentials: A Pilot Study
  171. Somatosensory cortex excitability: a child is not a small adult
  172. Dorsal column nuclei evoked activity recorded from the human pedunculopontine nucleus
  173. Pain Assessment in Neurodegenerative Diseases
  174. Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives
  175. Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor
  176. Low- and high-frequency subcortical SEP amplitude reduction during pure passive movement
  177. Cerebellar direct current stimulation modulates pain perception in humans
  178. Neurophysiologic peculiarities of pediatric primary headaches
  179. Non headache phenotypes in pediatric age
  180. P028. Childhood migraine, epilepsy and tics: Are there similarities in the psychological profile?
  181. P016. Congenital ataxia, hemiplegic migraine due to a novel mutation of CACNA1A: a case report
  182. P029. Migraine, body weight and psychological factors in children and adolescents
  183. O016. Does migraine follow benign paroxysmal torticollis?
  184. O019. Headache as an emergency in children and adolescents
  185. P047. Paroxysmal episodic hemicrania in a child. A complex differential diagnosis
  186. Abdominal acupuncture reduces laser-evoked potentials in healthy subjects
  187. Cortical inhibition of laser pain and laser-evoked potentials by non-nociceptive somatosensory input
  188. Increased habituation to painful stimuli: a self-protective mechanism during prolonged wakefulness?
  189. Migraine equivalents and related symptoms, psychological profile and headache features: which relationship?
  190. A New Method for Sham-Controlled Acupuncture in Experimental Visceral Pain - a Randomized, Single-Blinded Study
  191. Single-sweep spectral analysis of contact heat evoked potentials: a novel approach to identify altered cortical processing after morphine treatment
  192. Multifraction Radiotherapy for Palliation of Painful Bone Metastases: 20 Gy versus 30 Gy
  193. Impaired pain processing in patients with silent myocardial ischemia
  194. Headache as an Emergency in Children and Adolescents
  195. Structural Focal Temporal Lobe Seizures in a Child With Lipoproteinosis
  196. Migraine Equivalents as Part of Migraine Syndrome in Childhood
  197. Low and high-frequency somatosensory evoked potentials recorded from the human pedunculopontine nucleus
  198. Pharmacological and non-pharmacological treatment of pediatric primary headaches
  199. Trigeminal laser-evoked potentials: A neurophysiological tool to detect post-surgical outcome in trigeminovascular contact neuralgia
  200. Somatosensory system hyperexcitability in alternating hemiplegia of childhood
  201. Altered processing of sensory stimuli in patients with migraine
  202. Functional reorganization of brain networks in patients with painful chronic pancreatitis
  203. Electrophysiology as a tool to unravel the origin of pancreatic pain
  204. Primary headache pathophysiology in children: The contribution of clinical neurophysiology
  205. Different SEP recovery cycle in adolescent migraineurs with exploding or imploding pain
  206. Thinking of anything else does not always reduce pain: It depends on timing
  207. Clinical features, anger management and anxiety: a possible correlation in migraine children
  208. Cluster Headache in Childhood
  209. Peripheral and central nervous contribution to gastrointestinal symptoms in diabetic patients with autonomic neuropathy
  210. Clinical usefulness of laser evoked potentials
  211. Psychophysiological mechanisms underlying spatial attention in children with primary headache
  212. Targeting the Pedunculopontine Nucleus
  213. Erratum for Di Franco A, et al. “Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries” Am J Cardiol 2012;109:1705–1710
  214. Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries
  215. Uncertainty, misunderstanding and the pedunculopontine nucleus: the exhumation of an already buried dispute
  216. The use of muscle biopsy in the diagnosis of undefined ataxia with cerebellar atrophy in children
  217. Habituation to Pain in “Medication Overuse Headache”: A CO2 Laser-Evoked Potential Study
  218. Cerebral excitability is abnormal in patients with painful chronic pancreatitis
  219. Brain activity in rectosigmoid pain: Unravelling conditioning pain modulatory pathways
  220. Pregnancy-induced analgesia: a combined psychophysical and neurophysiological study
  221. Is urinary incontinence a true consequence of deep brain stimulation of the pedunculopontine tegmental nucleus in Parkinson’s disease?
  222. Brain source connectivity reveals the visceral pain network
  223. Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials
  224. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers
  225. How much does the neurophysiological assessment of the nociceptive pathways cost?
  226. Evidence of different spinal pathways for the warmth evoked potentials
  227. Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis
  228. The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms
  229. Absent median nerve P14 far-field somatosensory evoked potential with persistent tibial nerve P30 component in a patient with ischemic pontine lesion
  230. Reply: Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?
  231. Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?
  232. FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy–Walker malformation carrying a de novo 8p deletion
  233. Pain-Associated Adaptive Cortical Reorganisation in Chronic Pancreatitis
  234. Triptans other than sumatriptan in child and adolescent migraine: literature review
  235. Chronic paroxysmal hemicrania in paediatric age: report of two cases
  236. Childhood refractory focal epilepsy following acute febrile encephalopathy
  237. Effect of movement on SEPs generated by dorsal column nuclei
  238. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study
  239. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials
  240. Neurophysiological studies in alternating hemiplegia of childhood
  241. Familial hypobetalipoproteinemia: early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation
  242. Somatosensory system excitability in migraine
  243. Pain perception and laser evoked potentials during menstrual cycle in migraine
  244. Inverse Modeling on Decomposed Electroencephalographic Data: A Way Forward?
  245. The Abnormal Recovery Cycle of Somatosensory Evoked Potential Components in Children with Migraine can be Reversed by Topiramate
  246. Brain-evoked potentials as a tool for diagnosing neuropathic pain
  247. Laser evoked potential recording from intracerebral deep electrodes
  248. Correlation Between Abnormal Brain Excitability and Emotional Symptomatology in Paediatric Migraine
  249. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: Evidence for an abnormal nociceptive processing
  250. Learning potentiates neurophysiological and behavioral placebo analgesic responses
  251. Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X ☆
  252. The Child With Headache in a Pediatric Emergency Department
  253. Abnormal processing of the nociceptive input in Parkinson’s disease: A study with CO2 laser evoked potentials
  254. Seeing the pain of others while being in pain: A laser-evoked potentials study
  255. Pre-stimulus alpha power affects vertex N2–P2 potentials evoked by noxious stimuli
  256. Nociceptive contribution to the evoked potentials after painful intramuscular electrical stimulation
  257. New depth short-latency somatosensory evoked potential (SEP) component recorded in human SI area
  258. Unmasking of presynaptic and postsynaptic high-frequency oscillations in epidural cervical somatosensory evoked potentials during voluntary movement
  259. Brain excitability in migraine: Hyperexcitability or inhibited inhibition?
  260. Parallel spinal pathways generate the middle-latency N1 and the late P2 components of the laser evoked potentials
  261. Inhibitory effect of voluntary movement preparation on cutaneous heat pain and laser-evoked potentials
  262. Pain in Chronic Pancreatitis: The Role of Reorganization in the Central Nervous System
  263. Giant subcortical high-frequency SEPs in idiopathic generalized epilepsy: A protective mechanism against seizures?
  264. Antiepileptic drugs in the preventive treatment of migraine in children and adolescents
  265. Cerebellar damage impairs detection of somatosensory input changes. A somatosensory mismatch-negativity study
  266. Distraction affects frontal alpha rhythms related to expectancy of pain: An EEG study
  267. The “human visceral homunculus” to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon
  268. Brainstem Dysfunction in Alternating Hemiplegia of Childhood
  269. Cerebral processing of painful oesophageal stimulation: a study based on independent component analysis of the EEG
  270. Chapter 17 Laser evoked potentials in primary headaches: a possible clinical or research tool?
  271. Chapter 31 Application of dipole models in exploring somatosensory evoked potential sources
  272. Cortical changes to experimental sensitization of the human esophagus
  273. Effects of transcutaneous electrical nerve stimulation on motor cortex excitability in writer's cramp: Neurophysiological and clinical correlations
  274. Modulation of laser-evoked potentials by experimental cutaneous tonic pain
  275. Attentional load of the primary task influences the frontal but not the temporal generators of mismatch negativity
  276. Is there a role of clinical neurophysiology in primary headache?
  277. Multilevel somatosensory system disinhibition in children with migraine
  278. Short and middle-latency Median Nerve (MN) SEPs recorded by depth electrodes in human pre-SMA and SMA-proper
  279. Increase of brain-stem high-frequency SEP subcomponents during light sleep in seizure-free epileptic patients
  280. Attentional training in elderly subjects affects voluntarily oriented, but not automatic attention: A neurophysiological study
  281. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X
  282. Abnormal cortical pain processing in patients with cardiac syndrome X
  283. Amplitude reduction of the epidural cervical SEPs during voluntary movement
  284. Abnormal cortical pain processing in patients with cardiac syndrome X
  285. Cortical neuroplastic changes to painful colon stimulation in patients with irritable bowel syndrome
  286. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials
  287. Corrigendum to "The effects of aging on selective attention to touch: a reduced inhibitory control in elderly subjects?" [International Journal of Psychophysiology 49 (2003) 75–87]
  288. Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle pain
  289. Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients
  290. Long-lasting modulation of human motor cortex following prolonged transcutaneous electrical nerve stimulation (TENS) of forearm muscles: evidence of reciprocal inhibition and facilitation
  291. Pain evaluation and management: a survey of Italian radiotherapists
  292. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials
  293. Brain-stem components of high-frequency somatosensory evoked potentials are modulated by arousal changes: nasopharyngeal recordings in healthy humans
  294. Erratum
  295. Dipolar source modelling of brain potentials evoked by painful electrical stimulation of the human sigmoid colon
  296. Parietal generators of low- and high-frequency MN (median nerve) SEPs: data from intracortical human recordings
  297. Assessing somatosensory evoked potential (SEP) generators by human intracranial recordings
  298. Different neuronal contribution to N20 somatosensory evoked potential and to CO2 laser evoked potentials: an intracerebral recording study
  299. Functional assessment of A? and C fibers in patients with Fabry's disease
  300. Plastic interactions between hand and face cortical representations in patients with trigeminal neuralgia: a somatosensory-evoked potentials study
  301. Reduction in amplitude of the subcortical low- and high-frequency somatosensory evoked potentials during voluntary movement: an intracerebral recording study
  302. Brain generators of laser-evoked potentials: from dipoles to functional significance
  303. Short-term plastic changes of the human nociceptive system following acute pain induced by capsaicin
  304. Reduced habituation to experimental pain in migraine patients: a CO2 laser evoked potential study
  305. Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials
  306. The effects of aging on selective attention to touch: a reduced inhibitory control in elderly subjects?
  307. The human supplementary motor area-proper does not receive direct somatosensory inputs from the periphery: data from stereotactic depth somatosensory evoked potential recordings
  308. Effect Of Phasic And Tonic Pain on the Motor System: Neurorehabilitative Implications
  309. Cervical cord dysfunction during neck flexion in Hirayama's disease
  310. Unmyelinated trigeminal pathways as assessed by laser stimuli in humans
  311. Cerebellar ataxia and coenzyme Q10 deficiency
  312. Pain-related modulation of the human motor cortex
  313. Abnormal brain processing of cutaneous pain in patients with chronic migraine
  314. Abnormal gating of somatosensory inputs in essential tremor
  315. On the outcome in stroke patients one year later: the role of atrial fibrillation
  316. Attention-related modifications of ultra-late CO2 laser evoked potentials to human trigeminal nerve stimulation
  317. Dissociated changes of somatosensory evoked low-frequency scalp responses and 600 Hz bursts after single-dose administration of lorazepam
  318. Distinct fronto-central N60 and supra-sylvian N70 middle-latency components of the median nerve SEPs as assessed by scalp topographic analysis, dipolar source modelling and depth recordings
  319. Modality-related scalp responses after electrical stimulation of cutaneous and muscular upper limb afferents in humans
  320. Contribution of GABAergic cortical circuitry in shaping somatosensory evoked scalp responses: specific changes after single-dose administration of tiagabine
  321. Dipolar modelling of the scalp evoked potentials to painful contact heat stimulation of the human skin
  322. Transient inhibition of the human motor cortex by capsaicin-induced pain. A study with transcranial magnetic stimulation
  323. Source generators of the early somatosensory evoked potentials to tibial nerve stimulation: an intracerebral and scalp recording study
  324. Inhibition of motor system excitability at cortical and spinal level by tonic muscle pain
  325. Inhibition of biceps brachii muscle motor area by painful heat stimulation of the skin
  326. Functional changes of the primary somatosensory cortex in patients with unilateral cerebellar lesions
  327. Characterizing somatosensory evoked potential sources with dipole models: Advantages and limitations
  328. Characterizing somatosensory evoked potential sources with dipole models: Advantages and limitations
  329. Dipolar source modeling of the P300 event-related potential after somatosensory stimulation
  330. Long-lasting effect evoked by tonic muscle pain on parietal EEG activity in humans
  331. Unmasking of an early laser evoked potential by a point localization task
  332. Scalp distribution of the earliest cortical somatosensory evoked potential to tibial nerve stimulation: proposal of a new recording montage
  333. Dipolar source modeling of somatosensory evoked potentials to painful and nonpainful median nerve stimulation
  334. Somatosensory evoked potentials after multisegmental lower limb stimulation in focal lesions of the lumbosacral spinal cord
  335. Sources of cortical responses to painful CO 2 laser skin stimulation of the hand and foot in the human brain
  336. Central scalp projection of the N30 SEP source activity after median nerve stimulation
  337. Open-door laminoplasty for cervical stenotic myelopathy: surgical technique and neurophysiological monitoring
  338. Dipolar source modeling of somatosensory evoked potentials to painful and nonpainful median nerve stimulation
  339. Effect of movement on dipolar source activities of somatosensory evoked potentials
  340. Inhibition of the human primary motor area by painful heat stimulation of the skin
  341. Different contribution of joint and cutaneous inputs to early scalp somatosensory evoked potentials
  342. Clinical and neurophysiological abnormalities before and after reconstruction of the anterior cruciate ligament of the knee
  343. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy
  344. The scalp to earlobe montage as standard in routine SEP recording. Comparison with the non-cephalic reference in patients with lesions of the upper cervical cord
  345. Selective abnormality of the N13 spinal SEP to dermatomal stimulation in patients with cervical monoradiculopathy
  346. Dipolar sources of the early scalp somatosensory evoked potentials to upper limb stimulation
  347. Dissociation induced by voluntary movement between two different components of the centro-parietal P40 SEP to tibial nerve stimulation
  348. Dipolar generators of the early scalp somatosensory evoked potentials to tibial nerve stimulation in human subjects
  349. Abnormalities of somatosensory and motor evoked potentials in adrenomyeloneuropathy: Comparison with magnetic resonance imaging and clinical findings
  350. Ischaemic myelopathy associated with cocaine: clinical, neurophysiological, and neuroradiological features
  351. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement
  352. Functional involvement of central nervous system in mitochondrial disorders
  353. The pathophysiology of giant SEPs in cortical myoclonus: a scalp topography and dipolar source modelling study
  354. Giant central N20-P22 with normal area 3b N20-P20: an argument in favour of an area 3a generator of early median nerve cortical SEPs?
  355. Scalp topography and dipolar source modelling of potentials evoked by CO2 laser stimulation of the hand
  356. Spinal responses to median and tibial nerve stimulation and magnetic resonance imaging in intramedullary cord lesions
  357. Brain-stem somatosensory dysfunction in a case of long-standing left hemispherectomy with removal of the left thalamus: a nasopharyngeal and scalp SEP study
  358. Central nervous system modifications in patients with lesion of the anterior cruciate ligament of the knee
  359. Origin and distribution of P13 and P14 far-field potentials after median nerve stimulation. Scalp, nasopharyngeal and neck recording in healthy subjects and in patients with cervical and cervico-medullary lesions
  360. Recovery after surgery of the spinal N24 SEP in dural arteriovenous malformation of the dorsal cord
  361. The role of upper limb somatosensory evoked potentials in the management of cervical spondylotic myelopathy: preliminary data
  362. Somatosensory evoked potentials after multisegmental upper limb stimulation in diagnosis of cervical spondylotic myelopathy.
  363. N24 spinal response to tibial nerve stimulation and magnetic resonance imaging in lesions of the lumbosacral spinal cord
  364. Segmental dysfunction of the cervical cord revealed by abnormalities of the spinal N13 potential in cervical spondylotic myelopathy